MENTARI THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$12.20
-23.75%
Alpha Vantage · 11/10/2026
One-year price history
Adjusted daily closes · 252 observations · as of Nov 10, 2026
1 month
-10.3%
3 months
-15.3%
6 months
+86.3%
1 year
-24.7%
Year to date
+15.1%
52-week range
$6.15 – $18.50
Fundamental snapshot
Latest reported period: Sep 30, 2026
Market cap
$6.7M
P/E
-0.5
P/B
-5.6
P/S
8.2
Revenue
$820.19K
Net income
-$13.16M
Diluted EPS
-30.9
Gross margin
22.50%
Net margin
-1657.70%
Return on equity
-332.50%
Total debt
$0
Cash
$1.09M
Free cash flow
-$8.18M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 30, 2026 | $0 | -$2.33M | — | — | -$1.14M |
| Jun 30, 2026 | $0 | -$5.84M | — | — | -$2.96M |
| Mar 31, 2026 | $0 | -$2.97M | — | — | -$1.7M |
| Dec 31, 2025 | $820.19K | -$2.03M | 22.50% | -247.30% | -$2.38M |
| Sep 30, 2025 | $1.12M | -$1.73M | 36.00% | -154.20% | -$1.61M |
| Jun 30, 2025 | $1.3M | -$1.79M | 44.20% | -137.10% | -$1.78M |
| Mar 31, 2025 | $1.26M | -$2.12M | 13.90% | -168.10% | -$1.66M |
| Mar 31, 2025 | $1.26M | -$2.12M | 13.90% | -168.10% | -$1.66M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent MTRI news
All market newsNo ticker-linked stories are in the current archive.